Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Apr;35(4):856–861. doi: 10.1128/jcm.35.4.856-861.1997

Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.

T M Díaz-Guerra 1, J V Martínez-Suárez 1, F Laguna 1, J L Rodríguez-Tudela 1
PMCID: PMC229690  PMID: 9157142

Abstract

Candida albicans strain delineation by karyotyping. NotI restriction pattern analysis, hybridization with specific probe 27A, and PCR fingerprinting with the phage M13 core sequence were performed with 30 isolates from the oral cavities of 30 human immunodeficiency virus (HIV)-infected patients and 8 reference strains. Within the panel of clinical isolates, 20 were geographically related, although 10 isolates were susceptible to fluconazole and 10 isolates were resistant to fluconazole. The remaining isolates used in this study were fluconazole resistant and geographically unrelated. A composite DNA type was defined for each of the strains as the combination of types obtained by the four molecular methods. By this procedure, a great diversity of DNA types was found among isolates from the oropharynges of HIV-infected individuals with oral candidiasis. This diversity was not reduced when isolates were evaluated on the basis of whether they came from the same geographical locale and whether they were fluconazole resistant. These data refute the idea of a clonal origin for fluconazole-resistant strains among HIV-positive patients. Karyotyping was the least discriminatory method, yielding 19 DNA types among the 38 strains analyzed. Conversely, hybridization with the 27A probe showed a unique DNA pattern for each of the strains examined in this study. Our results demonstrate that at least two different molecular methods are needed for Candida albicans typing and that there is a great deal of strain variation within the species, irrespective of place of origin or antifungal resistance patterns.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barchiesi F., Hollis R. J., McGough D. A., Scalise G., Rinaldi M. G., Pfaller M. A. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis. 1995 Mar;20(3):634–640. doi: 10.1093/clinids/20.3.634. [DOI] [PubMed] [Google Scholar]
  2. Bart-Delabesse E., van Deventer H., Goessens W., Poirot J. L., Lioret N., van Belkum A., Dromer F. Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit. J Clin Microbiol. 1995 Dec;33(12):3278–3283. doi: 10.1128/jcm.33.12.3278-3283.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berenguer J., Diaz-Guerra T. M., Ruiz-Diez B., Bernaldo de Quiros J. C., Rodriguez-Tudela J. L., Martinez-Suarez J. V. Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient. J Clin Microbiol. 1996 Jun;34(6):1542–1545. doi: 10.1128/jcm.34.6.1542-1545.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hellstein J., Vawter-Hugart H., Fotos P., Schmid J., Soll D. R. Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J Clin Microbiol. 1993 Dec;31(12):3190–3199. doi: 10.1128/jcm.31.12.3190-3199.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lischewski A., Ruhnke M., Tennagen I., Schönian G., Morschhäuser J., Hacker J. Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles. J Clin Microbiol. 1995 Mar;33(3):769–771. doi: 10.1128/jcm.33.3.769-771.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lupetti A., Guzzi G., Paladini A., Swart K., Campa M., Senesi S. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J Clin Microbiol. 1995 May;33(5):1238–1242. doi: 10.1128/jcm.33.5.1238-1242.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Magee P. T., Bowdin L., Staudinger J. Comparison of molecular typing methods for Candida albicans. J Clin Microbiol. 1992 Oct;30(10):2674–2679. doi: 10.1128/jcm.30.10.2674-2679.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Martinez-Suarez J. V., Rodriguez-Tudela J. L. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob Agents Chemother. 1995 Jul;39(7):1512–1516. doi: 10.1128/aac.39.7.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pfaller M. A., Rhine-Chalberg J., Redding S. W., Smith J., Farinacci G., Fothergill A. W., Rinaldi M. G. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol. 1994 Jan;32(1):59–64. doi: 10.1128/jcm.32.1.59-64.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Powderly W. G., Robinson K., Keath E. J. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis. 1993 Aug;168(2):463–466. doi: 10.1093/infdis/168.2.463. [DOI] [PubMed] [Google Scholar]
  11. Rex J. H., Rinaldi M. G., Pfaller M. A. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother. 1995 Jan;39(1):1–8. doi: 10.1128/aac.39.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rodríguez-Tudela J. L., Martínez-Suárez J. V., Dronda F., Laguna F., Chaves F., Valencia E. Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J Antimicrob Chemother. 1995 Jun;35(6):793–804. doi: 10.1093/jac/35.6.793. [DOI] [PubMed] [Google Scholar]
  13. Sangeorzan J. A., Bradley S. F., He X., Zarins L. T., Ridenour G. L., Tiballi R. N., Kauffman C. A. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994 Oct;97(4):339–346. doi: 10.1016/0002-9343(94)90300-x. [DOI] [PubMed] [Google Scholar]
  14. Sangeorzan J. A., Zervos M. J., Donabedian S., Kauffman C. A. Validity of contour-clamped homogeneous electric field electrophoresis as a typing system for Candida albicans. Mycoses. 1995 Jan-Feb;38(1-2):29–36. doi: 10.1111/j.1439-0507.1995.tb00005.x. [DOI] [PubMed] [Google Scholar]
  15. Scherer S., Stevens D. A. A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1452–1456. doi: 10.1073/pnas.85.5.1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schmid J., Odds F. C., Wiselka M. J., Nicholson K. G., Soll D. R. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol. 1992 Apr;30(4):935–941. doi: 10.1128/jcm.30.4.935-941.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schönian G., Meusel O., Tietz H. J., Meyer W., Gräser Y., Tausch I., Presber W., Mitchell T. G. Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses. 1993 May-Jun;36(5-6):171–179. doi: 10.1111/j.1439-0507.1993.tb00746.x. [DOI] [PubMed] [Google Scholar]
  18. Vassart G., Georges M., Monsieur R., Brocas H., Lequarre A. S., Christophe D. A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA. Science. 1987 Feb 6;235(4789):683–684. doi: 10.1126/science.2880398. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES